because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
for example, Gluten-Free, Non-GMO, Vegan, etc
Both peptides arrive in separate vials to maintain individual compound integrity until reconstitution
If swallowing a daily pill appeals more than coping with weekly injections, the oral form might be preferable, particularly for those with needle aversion or frequent travelers
"Roses are Red, Violets are Blue, the Cardi B & Offset Meal is Coming to a McDonald's Near You"
Compounded concentrations may vary between pharmacies
